GoodRx Holdings, Inc. - Common Stock (GDRX)

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock
Shares outstanding
98,685,316
Total 13F shares
137,728,416
Share change
+3,959,214
Total reported value
$775,404,583
Put/Call ratio
98%
Price per share
$5.63
Number of holders
151
Value change
+$22,462,538
Number of buys
77
Number of sells
69

Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q3 2023

As of 30 Sep 2023, GoodRx Holdings, Inc. - Common Stock (GDRX) was held by 151 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 137,728,416 shares. The largest 10 holders included Francisco Partners Management, LP, VANGUARD GROUP INC, Silver Lake Group, L.L.C., RENAISSANCE TECHNOLOGIES LLC, AMERIPRISE FINANCIAL INC, Petrus Trust Company, LTA, BlackRock Inc., MORGAN STANLEY, SQN Investors LP, and Technology Crossover Management X, Ltd.. This page lists 151 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.